Welcome to Law.com Class Actions: Critical Mass, a weekly briefing for class action and mass tort attorneys. More than 3,100 opioid lawsuits remained pending against Endo, the latest drug manufacturer to file for Chapter 11 bankruptcy protection. After eight days of deliberations, the jury in a six-month trial over Flint, Michigan’s water contamination hit a breaking point. Find out who was appointed to lead class actions alleging embezzlement of the AME Church’s retirement plan.
I’m Amanda Bronstad. Feel free to reach out to me with your input. My email is [email protected], or follow me on Twitter: @abronstadlaw.
A logo sign outside of a facility occupied by Endo Pharmaceuticals in Malvern, Pennsylvania on May 30, 2015. Photo Credit: Kristoffer Tripplaar/ Sipa USAEndo Bankruptcy Comes With $450M Opioid Settlement
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]